PT Sarana Meditama Metropolitan Tbk (SAME.JK)
IDR 290.0
(-1.36%)
IDR 290.0
(-1.36%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1381.15 Billion IDR | 19.38% |
| 2022 | 1156.98 Billion IDR | 123.76% |
| 2021 | 517.05 Billion IDR | -61.52% |
| 2020 | 1343.76 Billion IDR | 7.04% |
| 2019 | 1255.39 Billion IDR | 4.36% |
| 2018 | 1202.94 Billion IDR | 78.89% |
| 2017 | 672.45 Billion IDR | 11.9% |
| 2016 | 600.93 Billion IDR | 30.06% |
| 2015 | 462.04 Billion IDR | 67.66% |
| 2014 | 275.58 Billion IDR | 12.65% |
| 2013 | 244.64 Billion IDR | -9.91% |
| 2012 | 271.55 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1408.28 Billion IDR | -2.43% |
| 2024 Q3 | 1371.42 Billion IDR | -2.62% |
| 2024 Q1 | 1443.29 Billion IDR | 4.5% |
| 2023 Q1 | 1177.94 Billion IDR | 1.81% |
| 2023 FY | 1381.15 Billion IDR | 19.38% |
| 2023 Q2 | 1167.3 Billion IDR | -0.9% |
| 2023 Q4 | 1381.15 Billion IDR | 3.06% |
| 2023 Q3 | 1340.2 Billion IDR | 14.81% |
| 2022 Q1 | 566.42 Billion IDR | 9.55% |
| 2022 Q2 | 1198.04 Billion IDR | 111.51% |
| 2022 FY | 1156.98 Billion IDR | 123.76% |
| 2022 Q3 | 1168.35 Billion IDR | -2.48% |
| 2022 Q4 | 1156.98 Billion IDR | -0.97% |
| 2021 Q4 | 517.05 Billion IDR | 69.21% |
| 2021 Q2 | 227.5 Billion IDR | -83.14% |
| 2021 Q1 | 1348.98 Billion IDR | 0.39% |
| 2021 FY | 517.05 Billion IDR | -61.52% |
| 2021 Q3 | 305.56 Billion IDR | 34.31% |
| 2020 Q3 | 1272.29 Billion IDR | 3.05% |
| 2020 FY | 1343.76 Billion IDR | 7.04% |
| 2020 Q2 | 1234.61 Billion IDR | -2.41% |
| 2020 Q4 | 1343.76 Billion IDR | 5.62% |
| 2020 Q1 | 1265.08 Billion IDR | 0.77% |
| 2019 Q3 | 1234.91 Billion IDR | 2.73% |
| 2019 FY | 1255.39 Billion IDR | 4.36% |
| 2019 Q4 | 1255.39 Billion IDR | 1.66% |
| 2019 Q2 | 1202.07 Billion IDR | -2.24% |
| 2019 Q1 | 1229.59 Billion IDR | 2.22% |
| 2018 Q1 | 691.83 Billion IDR | 2.88% |
| 2018 FY | 1202.94 Billion IDR | 78.89% |
| 2018 Q4 | 1202.94 Billion IDR | 9.66% |
| 2018 Q3 | 1096.94 Billion IDR | 47.68% |
| 2018 Q2 | 742.8 Billion IDR | 7.37% |
| 2017 Q1 | 610.77 Billion IDR | 1.64% |
| 2017 Q2 | 605.02 Billion IDR | -0.94% |
| 2017 FY | 672.45 Billion IDR | 11.9% |
| 2017 Q3 | 605.72 Billion IDR | 0.12% |
| 2017 Q4 | 672.45 Billion IDR | 11.02% |
| 2016 FY | 600.93 Billion IDR | 30.06% |
| 2016 Q4 | 600.93 Billion IDR | 1.89% |
| 2016 Q3 | 589.76 Billion IDR | -5.12% |
| 2016 Q2 | 621.56 Billion IDR | 23.05% |
| 2016 Q1 | 505.13 Billion IDR | 9.33% |
| 2015 Q2 | 372.93 Billion IDR | 28.34% |
| 2015 FY | 462.04 Billion IDR | 67.66% |
| 2015 Q1 | 290.57 Billion IDR | 5.44% |
| 2015 Q4 | 462.04 Billion IDR | 15.53% |
| 2015 Q3 | 399.91 Billion IDR | 7.24% |
| 2014 Q4 | 275.58 Billion IDR | -2.2% |
| 2014 Q1 | 257.6 Billion IDR | 5.3% |
| 2014 Q3 | 281.78 Billion IDR | 2.11% |
| 2014 FY | 275.58 Billion IDR | 12.65% |
| 2014 Q2 | 275.96 Billion IDR | 7.13% |
| 2013 Q4 | 244.64 Billion IDR | 18.67% |
| 2013 Q2 | 209.54 Billion IDR | -7.5% |
| 2013 Q1 | 226.53 Billion IDR | -16.58% |
| 2013 FY | 244.64 Billion IDR | -9.91% |
| 2013 Q3 | 206.14 Billion IDR | -1.62% |
| 2012 FY | 271.55 Billion IDR | 0.0% |
| 2012 Q4 | 271.55 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Bundamedik Tbk | 1283.12 Billion IDR | -7.64% |
| PT Metro Healthcare Indonesia Tbk | 1039.28 Billion IDR | -32.896% |
| PT Medikaloka Hermina Tbk | 3604.32 Billion IDR | 61.68% |
| PT Mitra Keluarga Karyasehat Tbk | 741.05 Billion IDR | -86.376% |
| PT Murni Sadar Tbk | 708.74 Billion IDR | -94.874% |
| PT Famon Awal Bros Sedaya Tbk | 1769.45 Billion IDR | 21.944% |
| PT Royal Prima Tbk | 49.68 Billion IDR | -2679.809% |
| PT Kedoya Adyaraya Tbk | 77.63 Billion IDR | -1679.068% |
| PT Siloam International Hospitals Tbk | 2934.42 Billion IDR | 52.933% |
| PT Sejahteraraya Anugrahjaya Tbk | 3748.83 Billion IDR | 63.158% |